5-cyclopropyl-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-4(3H)-imine 5-环丙基-2-(1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-基)嘧啶-4-胺
CAS 256376-24-6 MFCD56376246
化学结构图
SMILES:
化学属性
| Mol. Formula | C20H17FN6 |
|---|---|
| Mol. Weight | 360 |
别名和识别编码
| Chemical Name | 5-cyclopropyl-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-4(3H)-imine |
|---|---|
| Chemical Name Translation | 5-环丙基-2-(1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-基)嘧啶-4-胺 |
| MDL Number | |
| CAS Number | 256376-24-6 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Boerrigter G, et al. Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure. Circulation. 2003 Feb 11;107(5):686-9.
- [1]. Tuttle TR, et al. The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma. Cancer Lett. 2016 Jan 28;370(2):279-85.
- [1]. Tuttle TR, et al. The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma. Cancer Lett. 2016 Jan 28;370(2):279-85.
- [2]. Boerrigter G, et al. Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure. Circulation. 2003 Feb 11;107(5):686-9.
